DAVID Y. GRAHAM, M.D.; CRAIG D. JOHNSON, M.D.; PHILIP S. BENTLIF, M.D.; JOHN R. KELSEY Jr., M.D.
Three patients with profuse diarrhea, hypokalemia, metastatic nonbeta islet cell carcinoma, and the absence of gastric hypersecretion were found to have elevated levels of vasoactive intestinal peptide. One patient also had elevated serum gastrin levels. Two patients experienced prolonged remissions of diarrhea after operations in which only tumor biopsies were done. These cases further implicate vasoactive intestinal peptide as the agent mediating the diarrhea in the syndrome of pancreatic cholera.
Learn more about subscription options.
Register Now for a free account.
GRAHAM DY, JOHNSON CD, BENTLIF PS, KELSEY JR. Islet Cell Carcinoma, Pancreatic Cholera, and Vasoactive Intestinal Peptide. Ann Intern Med. 1975;83:782–785. doi: 10.7326/0003-4819-83-6-782
Download citation file:
Published: Ann Intern Med. 1975;83(6):782-785.
Diarrhea, Gastroenterology/Hepatology, Hematology/Oncology, Pancreatic Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only